- LARGE ANIMAL MODELS CORE The Large Animal Models Core was developed at the time of the last competing renewal to address the concern that in vitro cell culture systems and small animal models have not always translated well to solving human health digestive disease problems. The core was designed to provide models more physiologically similar to people. Over the past 5-years, the CGIBD has developed and strengthened a Large Animal Models Core at the NC State University College of Veterinary Medicine focused on medical and surgical technologies in pigs. The overall goal of the core is to provide a cost-effective central resource for Center investigators wishing to understand mechanisms of digestive disease using large animals. This has been particularly successful for CGIBD members interested in esophageal disease, in large part because the pig has proven to be an excellent translational model of diseases such as eosinophilic esophagitis and gastroesophageal reflux disease. The pig esophagus contains esophageal submucosal glands as does the human esophagus, while mice lack these glands. Recent work through the core has helped to establish these glands as a progenitor cell source in the esophagus. Disease models of intestinal ischemia have also continued to be a critical component of the Core, again because pigs are thought to more closely resemble humans in terms of their response to ischemia. Ex vivo (Ussing chambers) and in vitro studies, particularly those involving large animal complex cell culture (2D and 3D) are now being offered to bolster the basic science output from large animals. Furthermore, because of novel ideas related to the interaction of the gastrointestinal tract and the microbiome, we now plan to introduce gnotobiotic pigs as an additional resource.
The specific aims of the core are: 1) to provide consultation with Core veterinarians to assess feasibility, logistics and study design; 2) to assist with procurement of animals, and 3) to coordinate animal procedures, including anesthesia, endoscopy, and surgery. The Core directors (Blikslager and Gonzalez) have a demonstrated track record in digestive disease and are board-certified veterinary specialists in surgery. Veterinary board-certified specialists in laboratory animal medicine, internal medicine, anesthesia, and advanced imaging (MRI, CT, nuclear medicine) are readily available from the NC State Veterinary Hospital. Newly renovated facilities funded in large part by an NIH G20 grant are crucial to the Core?s ability to offer medical, surgical and gnotobiotic capabilities adjacent to large animal research housing. Based on funded projects developed with the Large Animal Models Core and CGIBD investigators during the prior funded period, the Core will aim to have 4-6 projects running at any one time. Although the Core currently serves a small number of members, it provides a remarkable scientific impact on their research which would not be possible without the core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034987-36
Application #
10126001
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
36
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Dong, Jing; Levine, David M; Buas, Matthew F et al. (2018) Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol 16:1598-1606.e4
Truax, Agnieszka D; Chen, Liang; Tam, Jason W et al. (2018) The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis. Cell Host Microbe 24:364-378.e6
Palacios, Michelle; Miner, Taryn A; Frederick, Daniel R et al. (2018) Identification of Two Regulators of Virulence That Are Conserved in Klebsiella pneumoniae Classical and Hypervirulent Strains. MBio 9:
Williamson, Ian A; Arnold, Jason W; Samsa, Leigh Ann et al. (2018) A High-Throughput Organoid Microinjection Platform to Study Gastrointestinal Microbiota and Luminal Physiology. Cell Mol Gastroenterol Hepatol 6:301-319
Zhang, Cun-Jin; Wang, Chenhui; Jiang, Meiling et al. (2018) Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun 9:2745
Evon, Donna M; Golin, Carol E; Ruffin, Rachel et al. (2018) Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C. Pilot Feasibility Stud 4:92
Busch, Evan L; Don, Prabhani Kuruppumullage; Chu, Haitao et al. (2018) Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors. BMC Cancer 18:82
Herfarth, Hans; Barnes, Edward L; Valentine, John F et al. (2018) Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis. Gastroenterology 155:1098-1108.e9
Koutlas, N T; Eluri, S; Rusin, S et al. (2018) Impact of smoking, alcohol consumption, and NSAID use on risk for and phenotypes of eosinophilic esophagitis. Dis Esophagus 31:1-7
Reese, Aspen T; Cho, Eugenia H; Klitzman, Bruce et al. (2018) Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut. Elife 7:

Showing the most recent 10 out of 944 publications